Corrigendum to: “Assessing glibenclamide’s efficacy on functional recovery in aneurysmal subarachnoid hemorrhage: A meta-analysis of randomized controlled trials”
- 26 December 2025
- journal article
- review article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 262, 109294
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Assessing Glibenclamide’s efficacy on functional recovery in aneurysmal subarachnoid hemorrhage: A meta-analysis of randomized controlled trialsClinical Neurology and Neurosurgery, 2025
- The Effects of Glibenclamide on Cognitive Performance, Quality of Life, and Emotional Aspects Among Patients With Aneurysmal Subarachnoid Hemorrhage: A Randomized Controlled TrialWorld Neurosurgery, 2024
- Efficacy and Safety of Early Treatment with Glibenclamide in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized Controlled TrialNeurocritical Care, 2024
- Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage: a randomised, double-blind, placebo-controlled clinical trialStroke and Vascular Neurology, 2024
- Glibenclamide in aneurysmal subarachnoid hemorrhage: a randomized controlled clinical trialJournal of Neurosurgery, 2022